Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...
The company aims to bring its technology — a lab-free detection method for cancers, viruses, and bacteria — to market in 2026 ...
Co-Diagnostics, Inc. ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced ...
Northland Power Inc. ( NPI:CA) Q3 2025 Earnings Call November 13, 2025 10:00 AM EST ...
Mediafeed on MSN
At-home blood tests: How they work & tips for success
This article was reviewed by Darragh O’Carroll, MD. Understanding Blood Tests: How They Work and What They Can Tell You Blood ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Cornell researchers have developed a powerful new biosensor that reveals, in unprecedented detail, how and where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback